Non invasive cardiopulmonary testing has reached a critical mass in 2026, with the widespread adoption of "breathomics." This technology analyzes the chemical composition of exhaled breath to detect biomarkers of systemic inflammation, cardiac stress, and pulmonary infection. These respiratory disease diagnostic tools are now sensitive enough to detect early-stage lung cancer and heart failure...
จองคิวบริการ
NR tours
Youplay
NR shop
NR jobs
facebook th
thai 
English
French
Spanish
Portuguese
Italiano
Romaian
Portuguese (Brazil)
china